Schalkwijk, C. G.

Long-Term Effects of Metformin on Endothelial Function in Type 2 Diabetes: A Randomized Controlled Trial

de Jager, J., Kooy, A., Schalkwijk, C., van der Kolk, J., Lehert, P., Bets, D., Wulffelé, M. G., Donker, A. J., & Stehouwer, C. D. A. (2014) · Journal of Internal Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 129

Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults

Cordova, R., Knaze, V., Viallon, V., Rust, P., Schalkwijk, C. G., Weiderpass, E., Wagner, K.-H., Mayen-Chacon, A.-L., Aglago, E. K., Dahm, C. C., et al. (2020) · European Journal of Nutrition

Advanced Glycation End Products researchNutritional Studies and Diet

Cited by 62

The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1

van Eupen, M. G. A., Schram, M. T., Colhoun, H. M., Hanssen, N. M. J., Niessen, H. W. M., Tarnow, L., Parving, H. H., Rossing, P., Stehouwer, C. D. A., & Schalkwijk, C. G. (2013) · Diabetologia

Advanced Glycation End Products researchNitric Oxide and Endothelin Effects

Cited by 60

The hypoxia-sensor carbonic anhydrase IX affects macrophage metabolism, but is not a suitable biomarker for human cardiovascular disease

Demandt, J. A. F., Dubois, L. J., van Kuijk, K., Zaťovičová, M., Jin, H., Parkkila, S., van der Laan, S. W., Jelenska, L., Mees, B. M. E., Reutelingsperger, C. P. M., et al. (2021) · Scientific Reports

Enzyme function and inhibitionAtherosclerosis and Cardiovascular Diseases

Cited by 9